Hypoparathyroidism

Slide 1 · Hypoparathyroidism

Mechanisms, clinicopathologic manifestations, and endocrine differentials

Pathology lecture

Dr Abu Suraih Sakhri

MBBS, MD (Pathology)

www.abusuraihsakhri.com

Slide 2 · Learning objectives

Explain normal PTH feedback regulation and target-organ actions.

Differentiate surgical, autoimmune, inherited, and developmental causes.

Link hypocalcemia to neurologic, cardiac, ocular, and dental manifestations.

Distinguish PTH deficiency from PTH resistance.

Slide 3 · Core definition: Insufficient PTH action

Hypoparathyroidism is a state of deficient parathyroid hormone secretion or availability.

PTH normally increases ionized calcium through kidney, intestine, and bone.

Deficient hormone action leads to a tendency toward hypocalcemia.

PTH resistance produces a similar biochemical effect but is a distinct disorder.

Slide 4 · Normal feedback responds to a fall in calcium

Ionized Ca²⁺ falls

Signal sensed by parathyroid tissue

PTH rises

Compensatory secretion

Calcium rises

Renal, vitamin D, and skeletal effects

PTH declines

Negative feedback restored

The direction of the loop explains why absent PTH secretion is inappropriate during hypocalcemia.

Slide 5 · Parathyroid glands: Anatomy relevant to surgery

Usually four glands lie near the superior and inferior poles of the thyroid.

Developmental descent can leave ectopic glands along the migration pathway.

Documented ectopic sites include carotid sheath, thymus, and anterior mediastinum.

Anatomical variability helps explain inadvertent removal during cervical surgery.

Slide 6 · Normal parathyroid cell populations

Chief cells

Predominant cell type

PTH-containing secretory granules

Small polygonal cells with rounded nuclei

Oxyphil cells

Larger eosinophilic cells

Abundant mitochondria

Few or absent secretory granules

Schematic cellular comparison; Not a histologic photomicrograph.

Slide 7 · Calcium sensing controls PTH output

Lower extracellular Ca²⁺

Reduced sensing signal

Parathyroid response

PTH synthesis and release increase

Systemic effect

Calcium restoration

Calcium-sensing receptor behavior becomes a disease mechanism in activating CASR mutations.

Slide 8 · PTH conserves calcium in the kidney

PTH signal

Acts at renal tubules

Tubular Ca²⁺ reabsorption

Conserves filtered calcium

Blood ionized calcium

Supported by renal retention

Loss of PTH removes this calcium-conserving endocrine signal.

Slide 9 · PTH links kidney vitamin D to intestinal calcium

PTH at kidney

Promotes activation of vitamin D

Active vitamin D

Increases intestinal calcium absorption

Calcium entry

Supports extracellular calcium

PTH deficiency impairs the normal stimulation of this calcium-absorptive pathway.

Slide 10 · PTH promotes urinary phosphate excretion

PTH activity

Renal phosphate excretion increases

Blood phosphate

Concentration tends to fall

Free calcium

Reduced phosphate binding favors ionized calcium

Reduced PTH activity may permit phosphate retention; This relationship is central to tissue calcification.

Slide 11 · Skeletal contribution to PTH action

PTH signaling

Favors osteoclast differentiation

Bone resorption

Mineral is released

Extracellular Ca²⁺

Calcium concentration supported

PTH acts on calcium homeostasis in multiple organs, not only on bone.

Slide 12 · Three coordinated effects increase ionized calcium

Renal calcium

Tubular reabsorption conserves circulating calcium.

Active vitamin D

Intestinal calcium absorption increases.

Skeletal mineral

Osteoclast-mediated resorption releases calcium.

Renal phosphate excretion provides an additional calcium-favoring effect.

Slide 13 · Normal compensation versus hypoparathyroidism

Normal response to low Ca²⁺

PTH secretion increases

Renal calcium retention increases

Vitamin D activation increases

Phosphate excretion increases

Insufficient PTH

PTH response is inadequate

Calcium-conserving signals diminish

Intestinal support is reduced

Phosphate may accumulate

Slide 14 · Clinical severity depends on calcium deficit

The manifestations of hypoparathyroidism reflect the severity and chronicity of hypocalcemia.

Early neuromuscular excitability may be clinically striking.

Persistent biochemical disturbance is associated with organ-specific changes.

A patient’s phenotype reflects both intensity and duration of the deficit.

Slide 15 · Etiologic groups of hypoparathyroidism

Acquired

Inadvertent loss of parathyroid tissue after surgery.

Immune-mediated

APS-1 associated with AIRE pathway dysfunction.

Inherited/developmental

CASR, PTH, GCM2, or congenital gland absence.

Each route converges on insufficient effective PTH production.

Slide 16 · Surgery is the dominant acquired association

Acquired hypoparathyroidism as almost always an inadvertent consequence of surgery.

Loss of viable parathyroid tissue can follow surgery on the thyroid or neck.

Excessive removal of parathyroid tissue is another described setting.

Cause is loss of endocrine tissue rather than a PTH-secreting tumor.

Slide 17 · Three described surgical routes

Thyroidectomy

Accidental removal of all glands

Anatomical proximity creates the risk

Radical neck dissection

Glands may be mistaken for lymph nodes

Parathyroid tissue removed with neck specimen

Parathyroid surgery

Too much tissue excised

Can follow treatment of primary hyperparathyroidism

Slide 18 · Post-thyroidectomy hypocalcemia: Mechanism

Removal of parathyroid tissue prevents the normal compensatory PTH response.

Reduced PTH-dependent calcium retention and vitamin D activation follow.

Calcium falls despite the normal stimulus for PTH secretion.

The surgical context is a major etiologic clue.

Slide 19 · From gland loss to neuromuscular symptoms

Cervical surgery

Parathyroid tissue inadvertently removed

PTH insufficiency

Feedback cannot restore calcium

Hypocalcemia

Extracellular calcium remains low

Tetany

Neuromuscular irritability

A clinical sequence explains why prior surgery should be sought in the history.

Slide 20 · Operative context helps localize the risk

Thyroid operation

Parathyroid glands adjacent to thyroid poles

Removal can occur during thyroidectomy

Consider postoperative calcium disturbance

Neck tumor operation

Parathyroid may resemble a node

Removal can occur in radical dissection

Consider the full operative field

Slide 21 · APS-1: Characteristic clinical constellation

Candidiasis

Chronic mucocutaneous fungal infection.

Hypoparathyroidism

Autoimmune damage with hypocalcemia.

Adrenal insufficiency

Primary adrenal cortical insufficiency.

APS-1 is a syndromic cause: An isolated calcium result is not the full phenotype.

Slide 22 · APS-1: Typical clinical sequence

Childhood

Mucocutaneous candidiasis

Several years later

Hypoparathyroidism

Adolescence

Adrenal insufficiency

The sequence is typical, not a strict rule applying to every affected individual.

Slide 23 · AIRE preserves central T-cell tolerance

Functional AIRE

Peripheral tissue antigens expressed in thymus

T-cell selection

Self-reactive T cells eliminated

Self-tolerance

Reduced autoimmune injury

AIRE loss impairs central tolerance and predisposes to multiorgan autoimmune disease.

Slide 24 · AIRE loss permits autoimmune gland injury

AIRE dysfunction

Central tolerance is compromised

Self-reactive T cells

May escape elimination

Target-organ autoimmunity

Parathyroid and adrenal damage

Loss of immune tolerance provides the mechanistic connection between the APS-1 components.

Slide 25 · APS-1 candidiasis: Cytokine explanation

AIRE deficiency

APS-1 immune dysregulation

Anti-IL-17 / IL-22 antibodies

Impaired Th17-linked defense

Mucocutaneous candidiasis

Increased fungal susceptibility

Antibodies to IL-17 and IL-22 as a link to candidiasis.

Slide 26 · APS-1 versus APS-2: Clinically important distinction

APS-1

AIRE-associated syndrome

Hypoparathyroidism may occur

Mucocutaneous candidiasis

Primary adrenal insufficiency

APS-2

Adrenal insufficiency + autoimmune thyroiditis

May include type 1 diabetes

Not characterized by autoimmune hypoparathyroidism

Not characterized by candidiasis

Slide 27 · Activating CASR mutations alter the calcium set point

A gain-of-function CASR mutation makes parathyroid cells behave as though calcium is higher than it is.

The receptor responds excessively to extracellular calcium.

PTH secretion becomes inappropriately suppressed.

Patients develop hypocalcemia despite a low-calcium stimulus.

Slide 28 · CASR gain of function: Excessive calcium sensing

CASR activates too readily

Heightened calcium sensitivity

PTH secretion suppressed

Misleading signal of Ca²⁺ sufficiency

Hypocalcemia

Deficient correction of calcium deficit

Inherited activating CASR variants are a cause of autosomal dominant hypoparathyroidism.

Slide 29 · CASR activation and urinary calcium

Parathyroid effect

Heightened calcium sensing

PTH output decreases

Hypocalcemia develops

Renal phenotype

Hypercalciuria accompanies hypocalcemia

The combination is a clue to CASR activation

Do not assume every hypocalcemia implies low urine calcium

Slide 30 · CASR allelic effects are direction-dependent

Gain of function

Autosomal dominant hypoparathyroidism

Suppressed PTH

Hypocalcemia + hypercalciuria

Heterozygous loss of function

Familial hypocalciuric hypercalcemia

Reduced sensing of ambient calcium

Hypercalcemic phenotype

Homozygous loss of function

Severe neonatal primary hyperparathyroidism

Markedly defective sensing

Opposite functional direction from activating mutation

Slide 31 · Familial isolated hypoparathyroidism: Inheritance

Autosomal dominant FIH

Mutation of PTH gene

Impaired maturation of PTH peptide

Functionally inadequate active hormone

Autosomal recessive FIH

Loss of GCM2 function

Parathyroid developmental program impaired

Insufficient parathyroid gland development

Slide 32 · PTH gene variant blocks mature hormone generation

PTH gene mutation

Dominant familial isolated form

Impaired processing

Mature active hormone is not generated normally

PTH deficiency

Calcium homeostasis impaired

This mechanism concerns hormone processing, not tissue loss at surgery.

Slide 33 · GCM2 loss impairs gland development

GCM2 loss of function

Autosomal recessive familial form

Parathyroid development

Essential transcriptional control reduced

PTH deficiency

Inadequate functioning gland tissue

GCM2 and PTH gene variants produce deficiency through different biological levels.

Slide 34 · Different genetic lesions affect different levels

CASR

Calcium sensing defect

Excess suppression of secretion

Hypocalcemia with hypercalciuria

PTH

Hormone processing defect

Mature PTH impaired

Autosomal dominant FIH

GCM2

Developmental transcription factor

Parathyroid development impaired

Autosomal recessive FIH

Slide 35 · Congenital absence: A linked developmental pattern

Parathyroid absence

Defective gland development causes PTH deficiency.

Thymic defect

Thymic aplasia or hypoplasia may coexist.

Cardiac anomalies

Defects of the heart and great vessels may coexist.

The shared pharyngeal-pouch origin explains the organ constellation.

Slide 36 · 22q11 deletion disrupts pharyngeal development

22q11 region deletion

Includes developmental regulator TBX1

Abnormal pharyngeal development

Thymus and parathyroid affected

Syndromic phenotype

Tetany, T-cell deficiency, cardiac anomalies

DiGeorge syndrome denotes the 22q11-related pattern when thymic defects are present.

Slide 37 · Congenital hypoparathyroidism: Clinical clues

Parathyroid involvement

Hypocalcemia

Tetany

May be apparent early in life

Associated malformations

Thymic aplasia or hypoplasia

Cardiovascular defects

Supports syndromic congenital cause

Slide 38 · Hypocalcemia causes neuromuscular irritability

Tetany is the hallmark clinical manifestation of hypocalcemia.

Symptoms begin with sensory complaints or muscle spasms.

More severe disturbance can involve airway and cerebral function.

Neuromuscular symptoms should trigger a search for calcium disturbance.

Slide 39 · Tetany presents on a severity continuum

Sensory

Circumoral numbness and distal paresthesias.

Motor

Carpopedal spasm and involuntary muscle contraction.

Severe

Laryngospasm or generalized seizures.

Severity is not inferred from one symptom alone.

Slide 40 · Paresthesias: Earliest recognizable clues

Circumoral numbness is a characteristic sensory symptom.

Tingling of distal extremities reflects neuromuscular irritability.

These symptoms may precede overt sustained muscle spasm.

The clinical context determines whether PTH deficiency is plausible.

Slide 41 · Carpopedal spasm is a motor expression of tetany

Sustained involuntary contraction may involve the hands and feet.

It is a manifestation of low extracellular calcium.

The same motor irritability underlies the Trousseau maneuver.

A positive sign supports hypocalcemia but does not identify its cause.

Slide 42 · Severe tetany may become life-threatening

Laryngospasm and generalized seizures are severe manifestations of hypocalcemia.

Laryngospasm threatens airway patency.

Generalized seizures represent severe cerebral excitability.

These findings warrant urgent clinical assessment rather than routine follow-up.

Slide 43 · Chvostek sign: Facial nerve irritability

Tap facial nerve course

External stimulation

Facial muscle twitch

Eye, mouth, or nose muscles

Positive Chvostek sign

Suggests latent neuromuscular irritability

The sign may be elicited in subclinical disease; It does not determine the underlying etiology.

Slide 44 · Trousseau sign: Ischemic provocation of spasm

Inflate arm cuff

Distal circulation occluded for several minutes

Carpal spasm

Sustained muscular contraction

Positive Trousseau sign

Provoked tetanic response

The demonstration is a clinical sign of hypocalcemic neuromuscular excitability.

Slide 45 · Chvostek and Trousseau: Distinguish the maneuvers

Chvostek sign

Tap along facial nerve

Observe facial contraction

Eye / mouth / nose muscles

Trousseau sign

Inflate blood pressure cuff

Maintain several minutes

Observe carpal spasm

Slide 46 · Psychiatric and cognitive manifestations

Affective

Emotional instability, anxiety, or depression.

Cognitive

Confusion or behavioral change.

Severe

Hallucinations or frank psychosis.

Neuropsychiatric signs are associated with the systemic calcium disturbance.

Slide 47 · Basal ganglia calcification can accompany low calcium

Intracranial calcium deposition is described in chronic hypoparathyroidism.

Basal ganglia are specifically identified as a susceptible site.

Movement disorders resembling parkinsonism can coexist.

Tissue mineral deposition is not equivalent to circulating hypercalcemia.

Slide 48 · The apparent paradox: Hypocalcemia and calcification

PTH deficiency

Phosphate excretion reduced

Phosphate retention

Higher phosphate availability

Calcium-phosphate deposition

Vulnerable tissues calcify

Robbins frames phosphate-mediated deposition as a possible explanation, not a proven unique mechanism.

Slide 49 · Hypoparathyroidism may resemble parkinsonian disease

Basal ganglia involvement may produce parkinsonian-like movement disorders.

The clinical phenomenon is an extrapyramidal motor phenotype.

It should be interpreted with the broader electrolyte and endocrine picture.

Intracranial calcification is a reported association, not a universal feature.

Slide 50 · Raised intracranial pressure is another neurologic association

Hypoparathyroidism can be associated with increased intracranial pressure and papilledema.

Papilledema is a funduscopic consequence of raised intracranial pressure.

This differs from the acute excitability mechanism of tetany.

Chronically affected patients may have multiple neurologic manifestations.

Slide 51 · Ocular changes: Lens calcification and cataract

Chronic hypoparathyroidism can produce calcification of the lens and cataract formation.

The change is an ocular tissue manifestation, not merely transient paresthesia.

Chronicity is relevant when interpreting lens abnormalities.

Ocular and intracranial calcification share a mineral-deposition theme.

Slide 52 · Cardiac conduction: A prolonged QT interval

Hypocalcemia causes a characteristic QT-interval prolongation on ECG.

The electrophysiologic abnormality reflects disturbed calcium physiology.

It is a systemic manifestation of PTH-related hypocalcemia.

Do not confuse a conduction manifestation with an etiologic diagnosis.

Slide 53 · Dental abnormalities record early-life hypocalcemia

Tooth development

Dental hypoplasia

Defective enamel formation

Defective root formation

Eruption and tooth integrity

Failure of eruption

Abraded teeth

Carious teeth

Slide 54 · Why timing matters for dental abnormalities

Low calcium in early development

Disturbs formation of developing teeth

Defective mineralized structures

Enamel and roots may develop abnormally

Later dental phenotype

Hypoplasia, eruption failure, damaged teeth

Dentition provides a clue to the developmental timing of calcium deficiency.

Slide 55 · Acute versus chronic emphasis

Immediate excitability

Circumoral paresthesias

Carpopedal tetany

Laryngospasm / seizures

QT prolongation

Longer-standing associations

Basal ganglia calcifications

Movement disorders

Lens calcification / cataracts

Dental defects if onset is early

Teaching grouping reflects manifestations and chronicity, not rigid temporal diagnostic criteria.

Slide 56 · Three clinical domains to screen conceptually

Neurologic

Tetany, seizures, psychiatric symptoms, and basal ganglia changes.

Cardio-ocular

Prolonged QT; Lens calcification and cataract.

Developmental

Abnormal dental development after early hypocalcemia.

Organ involvement follows calcium imbalance rather than a mass-producing gland lesion.

Slide 57 · PTH deficiency versus PTH resistance

Hypoparathyroidism

Too little effective hormone is made

Common endpoint

Hypocalcemia develops

Pseudohypoparathyroidism

Target tissue fails to respond to PTH

Similar calcium results require different endocrine interpretation of circulating PTH.

Slide 58 · Interpret calcium together with circulating PTH

True hypoparathyroidism

Calcium low

PTH insufficient / inappropriately low

Hormone deficiency mechanism

Phosphate tends to be retained

Pseudohypoparathyroidism

Calcium low

PTH normal or elevated

End-organ PTH resistance

Hyperphosphatemia described

No numeric reference cutoffs are asserted; Biochemical descriptors are qualitative.

Slide 59 · Pseudohypoparathyroidism: PTH is present but ineffective

The defining lesion is end-organ resistance to PTH.

Circulating PTH is normal or elevated, unlike deficient secretion.

The classic pattern is hypocalcemia and hyperphosphatemia.

Clinical PTH resistance can coexist with resistance to other hormones.

Slide 60 · Post-receptor signaling explains multihormone resistance

Hormone binds GPCR

PTH, TSH, FSH/LH use receptor-linked signaling

Shared pathway defect

Genetic defects impair common signaling components

End-organ resistance

Biologic response becomes inadequate

Some pseudohypoparathyroidism forms to shared G-protein–coupled signaling defects.

Slide 61 · Pseudohypoparathyroidism can involve three endocrine axes

PTH

Most obvious resistance; Low calcium and high phosphate.

TSH

Resistance is generally mild.

FSH/LH

Female hypergonadotropic hypogonadism can occur.

Multihormone resistance is described in one form—not all forms.

Slide 62 · PTH deficiency versus receptor-pathway resistance

Hormone deficiency

Surgical or genetic causes of low PTH

Secretion or gland development impaired

Hypocalcemic manifestations

PTH itself is inadequate

PTH resistance

End-organ signal transduction impaired

PTH may be elevated

Hypocalcemia + hyperphosphatemia

Other GPCR hormones sometimes affected

Slide 63 · Etiologic diagnosis: Three high-yield clues

Operative history

Thyroid, radical neck, or parathyroid surgery.

Syndromic history

Candidiasis/adrenal disease or thymic/cardiac defects.

Inheritance pattern

CASR activation, PTH processing, or GCM2 developmental disorder.

Slide 64 · Case application: Post-thyroidectomy tetany

Clinical vignette

A patient develops circumoral tingling and carpopedal spasm after thyroidectomy.

Reason through the mechanism

Which endocrine tissue may have been removed? How does this cause the symptoms?

Slide 65 · Case application: Childhood candidiasis and tetany

Clinical vignette

A child has recurrent mucocutaneous candidiasis and later develops symptoms of hypocalcemia.

Reason through the mechanism

Which inherited autoimmune syndrome is suggested? Which later endocrine disorder is classically associated?

Slide 66 · Case application: Low calcium with high urinary calcium

Clinical vignette

A person with familial hypocalcemia also has hypercalciuria and an inappropriately suppressed PTH response.

Reason through the mechanism

Which calcium-sensing receptor change best explains the combined phenotype?

Slide 67 · Case application: Hypocalcemia plus thymic defects

Clinical vignette

An infant develops tetany and has a congenital cardiovascular anomaly and thymic hypoplasia.

Reason through the mechanism

Which shared developmental defect should be considered? What broad chromosomal syndrome is associated?

Slide 68 · Case application: Hypocalcemia despite elevated PTH

Clinical vignette

A patient has low calcium, high phosphate, and elevated circulating PTH. Mild TSH resistance is also suspected.

Reason through the mechanism

Is hormone deficiency or end-organ resistance the better model? Which signaling class is implicated?

Slide 69 · Hypocalcemia: Final etiologic comparison

Low PTH output

Postsurgical loss

APS-1 associated autoimmunity

PTH / GCM2 genetic defect

CASR gain of function

PTH resistance

PTH normal or elevated

Target-organ hormone signaling impaired

Low calcium / high phosphate

Additional hormone resistance in some forms

Slide 70 · Clinical synthesis: four mechanisms, one key phenotype

Hypocalcemia is the common consequence; etiology is determined by the failed step.

Loss of tissue: surgery or developmental absence.

Immune injury: APS-1 with AIRE dysfunction.

Altered gene function: CASR, PTH, or GCM2.

Target resistance: pseudohypoparathyroidism with PTH present.